MedTrace Logo

Prospective Study of Celiac Block Injection: 1 vs. 2

NCT00583479 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-09-12

No results posted yet for this study

Summary

The purpose of this prospective randomized study is to compare the clinical effectiveness of EUS-guided CB performed with a single injection versus two injections of medication into the celiac ganglion region.

Conditions

Interventions

OTHER

one injection into the celiac ganglion

one injection into the celiac ganglion of the standard medication for CB for with chronic pancreatitis or pancreatic cancer

OTHER

two injections into the celiac ganglion

two injection into the celiac ganglion of the standard medication for CB for with chronic pancreatitis or pancreatic cancer

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Julia LeBlanc, MD, MPH · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00583479 on ClinicalTrials.gov